Basic InvestigationFamilial Gelatinous Drop-Like Corneal Dystrophy Caused by a Novel Nonsense TACSTD2 MutationCabral-Macias, Jesus MD; Zenteno, Juan C. PhD; Ramirez-Miranda, Arturo MD; Navas, Alejandro MSc; Bermudez-Magner, Jose A. MD; Boullosa-Graña, Víctor M. MD; Graue-Hernandez, Enrique O. MSc; Buentello-Volante, Beatriz PhDAuthor Information *Department of Cornea and Refractive Surgery, Institute of Ophthalmology, Conde de Valenciana, Mexico City, Mexico; †Florida Lions Ocular Pathology Laboratory, Miami, FL; ‡Genetics Department-Research Unit, Institute of Ophthalmology, Conde de Valenciana, Mexico City, Mexico; §Department of Biochemistry, Faculty of Medicine, UNAM, Mexico City, Mexico; and ¶Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL. Reprints: Beatriz Buentello-Volante, PhD, Genetics Department-Research Unit, Institute of Ophthalmology, Conde de Valenciana, Chimalpopoca 14, Col. Obrera, Mexico City, CP 06800, Mexico (e-mail: [email protected]). Supported by the patronage of the Conde de Valenciana Foundation. The authors have no conflicts of interest to disclose. Received June 11, 2015 Received in revised form February 25, 2016 Accepted March 07, 2016 Cornea: July 2016 - Volume 35 - Issue 7 - p 987-990 doi: 10.1097/ICO.0000000000000863 Buy Metrics Abstract Purpose: To describe the clinical findings and results of molecular analysis in a Mexican family diagnosed with gelatinous drop-like corneal dystrophy (GDLD). Methods: Ophthalmological examination was performed in 1 unaffected and 4 affected relatives. Molecular analysis included polymerase chain reaction amplification and direct nucleotide sequencing of the entire TACSTD2 gene-coding region in genomic DNA. Results: The corneal phenotype in adult patients was characterized by white-yellow nodular lesions on the corneal surface and stromal neovascularization. Lesions were incipient in an affected relative aged 14 years. Nucleotide sequencing of the TACSTD2 gene demonstrated a homozygous c.331G>T transversion, which predicts a novel p.(E111*) nonsense mutation, in DNA of all 4 GDLD relatives. Conclusions: Our results expand the mutational spectrum of TACSTD2 in patients with GDLD. To the best of our knowledge, this is the first clinical and molecular description of patients with GDLD from Latin America. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.